179 related articles for article (PubMed ID: 25938291)
1. The United States Alpha-1 Foundation Research Registry: Genesis, Impact and Future.
Strange C; Monk R; Schwarz L; Walker D; Kumbhare S; Bieko T
COPD; 2015 May; 12 Suppl 1():42-5. PubMed ID: 25938291
[TBL] [Abstract][Full Text] [Related]
2. Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ Individuals.
Lara B; Miravitlles M
COPD; 2015 May; 12 Suppl 1():27-31. PubMed ID: 25938288
[TBL] [Abstract][Full Text] [Related]
3. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
[TBL] [Abstract][Full Text] [Related]
4. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.
O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG
COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284
[TBL] [Abstract][Full Text] [Related]
5. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
Piitulainen E; Mostafavi B; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
[TBL] [Abstract][Full Text] [Related]
6. Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.
de Serres FJ; Blanco I; Fernández-Bustillo E
COPD; 2006 Aug; 3(3):133-9. PubMed ID: 17240615
[TBL] [Abstract][Full Text] [Related]
7. The national alpha-1 antitrypsin deficiency registry in Poland.
Chorostowska-Wynimko J; Struniawski R; Sliwinski P; Wajda B; Czajkowska-Malinowska M
COPD; 2015 May; 12 Suppl 1():22-6. PubMed ID: 25938287
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.
Piitulainen E; Tanash HA
COPD; 2015 May; 12 Suppl 1():36-41. PubMed ID: 25938290
[TBL] [Abstract][Full Text] [Related]
9. [The German registry of individuals with alpha-1-antitrypsin deficiency--a source for research on patient care].
Koczulla R; Bittkowski N; Andress J; Greulich T; Schroth S; Kotke V; Vogelmeier C; Bals R
Pneumologie; 2008 Nov; 62(11):655-8. PubMed ID: 18855308
[TBL] [Abstract][Full Text] [Related]
10. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
[TBL] [Abstract][Full Text] [Related]
11. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
Strange C; Senior RM; Sciurba F; O'Neal S; Morris A; Wisniewski SR; Bowler R; Hochheiser HS; Becich MJ; Zhang Y; Leader JK; Methé BA; Kaminski N; Sandhaus RA;
Ann Am Thorac Soc; 2015 Oct; 12(10):1551-60. PubMed ID: 26153726
[TBL] [Abstract][Full Text] [Related]
12. Association of exposure to environmental tobacco smoke in childhood with chronic obstructive pulmonary disease and respiratory symptoms in adults.
Johannessen A; Bakke PS; Hardie JA; Eagan TM
Respirology; 2012 Apr; 17(3):499-505. PubMed ID: 22248329
[TBL] [Abstract][Full Text] [Related]
13. Asthma and allergy in alpha-1 antitrypsin deficiency.
Eden E; Strange C; Holladay B; Xie L
Respir Med; 2006 Aug; 100(8):1384-91. PubMed ID: 16403617
[TBL] [Abstract][Full Text] [Related]
14. [Detection of alpha-1 antitrypsin deficiency: A study on patients diagnosed with chronic obstructive pulmonary disease in primary health care].
García-Palenzuela R; Timiraos Carrasco R; Gómez-Besteiro MI; Lavia G; Lago Pose M; Lara B
Semergen; 2017; 43(4):289-294. PubMed ID: 27353138
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in alpha-1-antitrypsin deficiency lung disease-analysis from the German registry.
Fähndrich S; Herr C; Greulich T; Seibert M; Lepper PM; Bernhard N; Lützow C; Vogelmeier C; Bals R
COPD; 2015 May; 12 Suppl 1():58-62. PubMed ID: 25938294
[TBL] [Abstract][Full Text] [Related]
16. Genetic testing of minors for alpha1-antitrypsin deficiency.
Strange C; Moseley MA; Jones Y; Schwarz L; Xie L; Brantly ML
Arch Pediatr Adolesc Med; 2006 May; 160(5):531-4. PubMed ID: 16651497
[TBL] [Abstract][Full Text] [Related]
17. Activity of the alpha-1 antitrypsin deficiency registry in Belgium.
Hutsebaut J; Janssens W; Louis R; Willersinn F; Stephenne X; Sokal E; Derom E
COPD; 2015 May; 12 Suppl 1():10-4. PubMed ID: 25938285
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency.
Ferrarotti I; Baccheschi J; Zorzetto M; Tinelli C; Corda L; Balbi B; Campo I; Pozzi E; Faa G; Coni P; Massi G; Stella G; Luisetti M
J Med Genet; 2005 Mar; 42(3):282-7. PubMed ID: 15744045
[No Abstract] [Full Text] [Related]
19. Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42.
Schramm GR; Mostafavi B; Piitulainen E; Wollmer P; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2021; 16():3477-3485. PubMed ID: 34992356
[TBL] [Abstract][Full Text] [Related]
20. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure.
Jindal SK; Aggarwal AN; Chaudhry K; Chhabra SK; D'Souza GA; Gupta D; Katiyar SK; Kumar R; Shah B; Vijayan VK;
Indian J Chest Dis Allied Sci; 2006; 48(1):23-9. PubMed ID: 16482948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
